Ironwood Share Price

Ironwood Share Price

NASDAQ: IRWD | Small Cap | Healthcare
$4.68
-$0.03 (-0.53%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Ironwood Stock Performance

Open
$4.66
Prev. Close
$4.71
Circuit Range
N/A
Day Range
$4.64 - $4.86
Year Range
$2.96 - $5.76
Volume
2,45,890
Average Traded
$4.75

Ironwood Share Price Today

As of 22 November 2026, Ironwood Pharmaceuticals, Inc. Class A's share price is $4.68. The stock opened at $4.66, compared to its previous close of $4.71. During today's trading session, Ironwood Pharmaceuticals, Inc. Class A's share price traded between $4.64 and $4.86, with an average price of $4.75. Over the past 52 weeks, the stock has recorded a high of $5.76 and a low of $2.96. In terms of performance, Ironwood Pharmaceuticals, Inc. Class A's share price has risen by 30.73% over the last six months and is up 34.10% on a year-on-year basis.

Ironwood Share Price Chart

Line chart of the Ironwood price trend over the selected period. The price fell overall, ranging from 4.66 to 4.85, ending at 4.68.
$4.64$4.86
L
Show Current Price
H

Ironwood Stock Fundamentals & Key Indicators

Market Cap
$757.42M
PE Ratio (TTM)
5.20
Dividend Yield
0.00%
EPS (TTM)
$0.90
Revenue (TTM)
$296.15B
Return On Equity (TTM)
-153.95%
Profit Margin
8.11%
Debt to Equity
-3.34
Quarterly Earnings Growth YoY
2724.56%

Ironwood Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$47.71$106.51$113.04$133.04
Net Profit-$2.28$40.77$51.29$59.84
Net Profit Margin-4.78%38.28%45.37%44.98%
Income ChangeN/A1888.16%25.80%16.67%

Ironwood Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$410.60$442.74$351.41$296.15
Net Profit$175.07-$1002.24$0.88$24.02
Net Profit Margin42.64%-226.37%0.25%8.11%
Income ChangeN/A-672.48%100.09%2629.55%

Ironwood Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets122.72168.54237.79319.89
Current Assets274.18182.37233.29780.63
Total Assets396.9350.91471.071100.52
Non Current Liabilities416.52613.4541.27422.62
Current Liabilities242.2238.85276.125.53
Total Liabilities658.74652.24817.37448.14
Shareholders' Equity-261.84-301.34-346.3652.38

Ironwood Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating127.04103.55183.43273.76
Investing-0.03-0.14-1,026.32-0.14
Financing0.22-106.97277.16-237.55

About Ironwood

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Ironwood Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.53
$4.68
+34.24%
Oct 2026
$3.87
$3.49
-12.20%
Sep 2026
$4.23
$3.98
-6.25%
Aug 2026
$4.33
$4.24
+0.24%
Jul 2026
$4.18
$4.23
+0.24%
Jun 2026
$3.52
$4.22
+17.88%
May 2026
$4.13
$3.58
-13.11%
Apr 2026
$3.57
$4.12
+17.38%
Mar 2026
$3.27
$3.51
+3.08%
Feb 2026
$4.84
$3.40
-30.51%
Jan 2026
$4.59
$4.90
+45.83%
Dec 2025
$3.46
$3.36
-3.72%

Ironwood Share Price FAQs